Grupo Cibest stands as Colombia’s largest financial group, running primarily through Bancolombia along with digital offerings such as Nequi and operations across Central America. Its quarterly updates offer a useful gauge of banking conditions in Colombia and the wider Latin American lending landscape. This third-quarter release followed a particularly strong second quarter that featured record profitability and an updated 2026 outlook. The latest figures therefore help show whether the group can maintain loan expansion and profitability amid climbing funding costs, persistent inflation, and elevated benchmark rates. I’m also watching progress on key initiatives such as the Banistmo divestment and Nequi’s move to operate as an independent financing company.
For the third quarter of 2026, Grupo Cibest posted net income attributable to shareholders of COP 2.08 trillion, or COP 2,202 per share and USD 2.66 per ADR. That result marked a 23.81% drop from the prior quarter and a 2.97% decline from the same period last year, landing below the consensus estimate of roughly USD 2.87 per ADR. Net interest income reached COP 5.74 trillion, rising 15.78% year over year yet falling 4.88% sequentially as gains from financial instrument valuations normalized. Net interest margin eased 51 basis points to 7.43%. Gross loans totaled COP 274 trillion, advancing 4.31% from the second quarter and 9.67% year over year, while customer deposits increased 8.63% year over year to COP 275 trillion. Net loan-loss provisions rose 16.77% sequentially to COP 1.19 trillion, with the annualized cost of credit at 1.80% and 30-day and 90-day NPL ratios of 3.52% and 2.36%, respectively. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The report followed a stretch of strong momentum that included record return on equity and an upgraded full-year outlook. Against that backdrop, the sequential drop in net income and the modest earnings-per-ADR shortfall shaped the initial reading. Key factors behind the softer profit included normalized one-time valuation gains, higher deposit costs, and a sequential rise in loan-loss provisions. On the positive side, broad loan growth, steady deposits, and a still-solid ROE of 21.75% offered some balance. Overall, the tone reflected a weighing of near-term margin pressure against ongoing balance-sheet expansion.
Attention now turns to whether Grupo Cibest can hold its net interest margin steady as funding costs keep rising. The group had lifted its 2026 NIM guidance to 7.4%–7.6% and ROE guidance to 21%–22%, so the third-quarter numbers place the bank near the lower end of those ranges. Maintaining those targets will hinge on how loan yields adjust relative to deposit costs in the current rate environment. Asset quality remains another focus area. With the 30-day NPL ratio at 3.52% and cost of credit at 1.80%, investors will track whether consumer lending and the Nequi portfolio experience further weakness, especially after the August earthquake in parts of Colombia. Provisioning trends will help gauge earnings resilience. Strategic execution also matters. Nequi’s shift to an independent financing company, the completed Banistmo sale, and integration of Avista’s payroll-lending business all influence the longer-term growth path. Management comments on these moves, together with Colombia’s inflation and interest-rate path, should help shape the stock’s next steps.
From what I see, tools like Tickeron’s AI Screener help surface comparable names and sector trends quickly when reviewing results like these. It serves as a practical complement when building or refining a watchlist around financial stocks.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CIB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 24 cases where CIB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIB advanced for three days, in 259 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CIB as a result. In 43 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.
The Moving Average Convergence Divergence Histogram (MACD) for CIB turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 24 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
CIB moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CIB crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The Aroon Indicator for CIB entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 1 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CIB's P/B Ratio (0.001) is slightly lower than the industry average of (1.262). P/E Ratio (0.005) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.470) is also within normal values, averaging (1.190). Dividend Yield (0.060) settles around the average of (0.035) among similar stocks. CIB's P/S Ratio (1.355) is slightly lower than the industry average of (3.738).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CIB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks